Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK
Cannabis Law Report
DECEMBER 14, 2021
(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.
Let's personalize your content